This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Event: 2159

Key Event Title

A descriptive phrase which defines a discrete biological change that can be measured. More help

Influenza A virus (IAV) cell entry

Short name
The KE short name should be a reasonable abbreviation of the KE title and is used in labelling this object throughout the AOP-Wiki. More help
IAV cell entry
Explore in a Third Party Tool

Biological Context

Structured terms, selected from a drop-down menu, are used to identify the level of biological organization for each KE. More help
Level of Biological Organization
Cellular

Cell term

The location/biological environment in which the event takes place.The biological context describes the location/biological environment in which the event takes place.  For molecular/cellular events this would include the cellular context (if known), organ context, and species/life stage/sex for which the event is relevant. For tissue/organ events cellular context is not applicable.  For individual/population events, the organ context is not applicable.  Further information on Event Components and Biological Context may be viewed on the attached pdf. More help
Cell term
respiratory epithelial cell

Organ term

The location/biological environment in which the event takes place.The biological context describes the location/biological environment in which the event takes place.  For molecular/cellular events this would include the cellular context (if known), organ context, and species/life stage/sex for which the event is relevant. For tissue/organ events cellular context is not applicable.  For individual/population events, the organ context is not applicable.  Further information on Event Components and Biological Context may be viewed on the attached pdf. More help
Organ term
respiratory tract

Key Event Components

The KE, as defined by a set structured ontology terms consisting of a biological process, object, and action with each term originating from one of 14 biological ontologies (Ives, et al., 2017; https://aopwiki.org/info_pages/2/info_linked_pages/7#List). Biological process describes dynamics of the underlying biological system (e.g., receptor signalling).Biological process describes dynamics of the underlying biological system (e.g., receptor signaling).  The biological object is the subject of the perturbation (e.g., a specific biological receptor that is activated or inhibited). Action represents the direction of perturbation of this system (generally increased or decreased; e.g., ‘decreased’ in the case of a receptor that is inhibited to indicate a decrease in the signaling by that receptor).  Note that when editing Event Components, clicking an existing Event Component from the Suggestions menu will autopopulate these fields, along with their source ID and description.  To clear any fields before submitting the event component, use the 'Clear process,' 'Clear object,' or 'Clear action' buttons.  If a desired term does not exist, a new term request may be made via Term Requests.  Event components may not be edited; to edit an event component, remove the existing event component and create a new one using the terms that you wish to add.  Further information on Event Components and Biological Context may be viewed on the attached pdf. More help
Process Object Action
protein localization to endosome clathrin-coated vesicle membrane occurrence
receptor-mediated endocytosis influenzavirus hemagglutinin occurrence
membrane fusion vesicle membrane occurrence

Key Event Overview

AOPs Including This Key Event

All of the AOPs that are linked to this KE will automatically be listed in this subsection. This table can be particularly useful for derivation of AOP networks including the KE.Clicking on the name of the AOP will bring you to the individual page for that AOP. More help
AOP Name Role of event in AOP Point of Contact Author Status OECD Status
IAV infection proliferation KeyEvent Jessica Resnick (send email) Under development: Not open for comment. Do not cite

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KE.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available in relation to this KE. More help
Term Scientific Term Evidence Link
human Homo sapiens High NCBI
dog Canis lupus familiaris High NCBI

Life Stages

An indication of the the relevant life stage(s) for this KE. More help
Life stage Evidence
All life stages Moderate

Sex Applicability

An indication of the the relevant sex for this KE. More help
Term Evidence
Unspecific High

Key Event Description

A description of the biological state being observed or measured, the biological compartment in which it is measured, and its general role in the biology should be provided. More help

IAV has two major surface proteins: hemagglutinin (HA) and neuraminidase (NA). HA binds to sialic acid glycans on the host cell surface to facilitate viral entry (1,2). Following this, the virion enters the cell through receptor—mediated endocytosis (usually involving clathrin) or micropinocytosis (1,3,4). The virus is then trafficked to the endosome, where the change in pH activates the M2 ion channel protein of the virus, leading to a conformational change in the HA exposing the fusion peptide and causing subsequent fusion of the viral envelope with the membrane of the vesicle (1). Following fusion, the vRNPs are released into the cytoplasm in a process known as “uncoating” and trafficked to the nucleus (1). This entire process takes about 10 minutes (5)

How It Is Measured or Detected

A description of the type(s) of measurements that can be employed to evaluate the KE and the relative level of scientific confidence in those measurements.These can range from citation of specific validated test guidelines, citation of specific methods published in the peer reviewed literature, or outlines of a general protocol or approach (e.g., a protein may be measured by ELISA). Do not provide detailed protocols. More help

Reference

Technique

Finding

Matlin, K.S., Reggio, H., Helenius, A. & Simons, K. Infectious entry pathway of influenza-virus in a canine kidney-cell line. J. Cell Biol. 91, 601–613 (1981)

Electron microscopy

Virus was seen bound to microvilli, in coated pits, coated vesicles, and large smooth-surfaced vacuoles, low pH was required for fusion, suggesting entry by endocytosis

Rust, M., Lakadamyali, M., Zhang, F. et al. Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol 11, 567–573 (2004). https://doi.org/10.1038/nsmb769

Real- time fluorescent microscopy

Clathrin-mediated and clathrin- and caveolin-independent endocytic pathways used in parallel with similar efficiency

De Vries, E. et. al., Dissection of the Influenza A Virus Endocytic Routes Reveals Macropinocytosis as an Alternative Entry Pathway. Plos Pathogens (2011). https://doi.org/10.1371/journal.ppat.1001329

Luciferase reporter assay

Macropinocytosis is an alternative entry pathway

Chen, C. and Zhuang, X. Epsin 1 is a cargo- specific adaptor for the clathrin-mediated endocytosis of the influenza virus

Colocalization of immunofluorescence

influenza entry via clathrin- mediated pathway

Sieczkarski, S. and Whittaker, G. Influenza Virus Can Enter and Infect Cells in the Absence of Clathrin-Mediated Endocytosis

Flow cytommetry

IAV cell entry via non-clathrin dependent route

Domain of Applicability

A description of the scientific basis for the indicated domains of applicability and the WoE calls (if provided).  More help

References

List of the literature that was cited for this KE description. More help
  1. Dou, D., et. al. Influenza A Virus Cell Entry, Replication, Virion Assembly, and Movement. Front. Immunol. (2018) https://doi.org/10.3389/fimmu.2018.01581
  2. Sempere Borau, M. and Stertz, S. Entry of influenza A virus into host cells- recent progress and remaining challenges. Current Opinion in Virology (2021) https://doi.org/10.1016/j.coviro.2021.03.001
  3. Matlin, K.S., Reggio, H., Helenius, A. & Simons, K. Infectious entry pathway of influenza-virus in a canine kidney-cell line. J. Cell Biol. 91, 601–613 (1981) https://doi.org/10.1083/jcb.91.3.601
  4. De Vries, E. et. al., Dissection of the Influenza A Virus Endocytic Routes Reveals Macropinocytosis as an Alternative Entry Pathway. Plos Pathogens (2011). https://doi.org/10.1371/journal.ppat.1001329
  5. Dou D, Hernandez-Neuta I, Wang H, Ostbye H, Qian X, Thiele S, et al. Analysis of IAV replication and co-infection dynamics by a versatile RNA viral genome labeling method. Cell Rep (2017) 20:251–63. doi:10.1016/j.celrep.2017.06.021